Skip to main content
Andrew Sikora, MD, Otolaryngology (ENT), Houston, TX

Andrew Gregory Sikora MD


Assistant Professor, Otolaryngology, Icahn School of Medicine

Join to View Full Profile
  • 1515 Holcombe BlvdHouston, TX 77030

  • Phone+1 713-792-6161

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 1 invite waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Andrew Sikora, MD is an otolaryngologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Alabama, and Arizona. He is an Assistant Professor at Icahn School of Medicine.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Otolaryngology - Head and Neck Surgery, 2001 - 2005
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineInternship, Otolaryngology - Head and Neck Surgery, 2000 - 2001
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • MS State Medical License
    MS State Medical License 2023 - 2025
  • OK State Medical License
    OK State Medical License 2023 - 2025
  • Otolaryngology
    American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • UTHealth Oral Surgeon Is the Second in US with Active R01 Grant Funding
    UTHealth Oral Surgeon Is the Second in US with Active R01 Grant FundingAugust 20th, 2021
  • PPIs Sensitize Cancer Cells to Radiation Therapy to Improve Tumor Control
    PPIs Sensitize Cancer Cells to Radiation Therapy to Improve Tumor ControlJuly 8th, 2021
  • Checkpoint Inhibitors with Surgery and Radiotherapy Offer Promise in Head and Neck Cancers
    Checkpoint Inhibitors with Surgery and Radiotherapy Offer Promise in Head and Neck CancersJune 6th, 2016
  • Join now to see all